Design, synthesis, anticancer evaluation, in silico docking and ADMET analysis of novel indole-based thalidomide analogs as promising immunomodulatory agents

References

• Abdelgawad, M. A., El-Adl, K., El-Hddad, S. S. A., Elhady, M. M., Saleh, N. M., Khalifa, M. M., Khedr, F., Alswah, M., Nayl, A. A., Ghoneim, M. M., & Abd El-Sattar, N. E. A. (2022). Design, molecular docking, synthesis, anticancer and anti-hyperglycemic assessments of thiazolidine-2,4-diones bearing sulfonylthiourea moieties as potent VEGFR-2 inhibitors and PPARγ agonists. Pharmaceuticals (Basel), 15(2), 226. https://doi.org/10.3390/ph15020226
   PubMedGoogle Scholar
• Alanazi, M. M., Elkady, H., Alsaif, N. A., Obaidullah, A. J., Alanazi, W. A., Al-Hossaini, A. M., Alharbi, M. A., Eissa, I. H., & Dahab, M. A. (2022). Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study. Journal of Molecular Structure, 1253, 132220. https://doi.org/10.1016/j.molstruc.2021.132220
   Web of Science ®Google Scholar
• Alanazi, M. M., Elkady, H., Alsaif, N. A., Obaidullah, A. J., Alkahtani, H. M., Alanazi, M. A., Alharbi, M. A., Eissa, I. H., & Dahab, M. A. (2021). New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Advances, 11(48), 30315–30328. https://doi.org/10.1039/d1ra05925d
   PubMed Web of Science ®Google Scholar
• Ali, F. T., Yousef, A. K., Ahmed, F. A., Elgneady, F. M., El-Adl, K., & Elhady, M. M. (2022). In silico ADMET, docking, anti-proliferative and antimicrobial evaluations of ethanolic extract of Euphorbia dendroides L. South African Journal of Botany, 150, 607–620. https://doi.org/10.1016/j.sajb.2022.08.009
   Web of Science ®Google Scholar
• Al-Qawasmeh, R., A. Khanfar, M., H. Semreen, M., Abu Odeh, R., & Al-Tel, T. H. (2013). Design and synthesis of new hybrid triazine-lndole derivatives as potential antimicrobial agents against hospital resistant strains. HETEROCYCLES, 87(11), 2385–2394. https://doi.org/10.3987/COM-13-12825
   Web of Science ®Google Scholar
• Alsaif, N. A., Taghour, M. S., Alanazi, M. M., Obaidullah, A. J., Al-Mehizia, A. A., Alanazi, M. A., Aldawas, S., Elwan, A., & Elkady, H. (2021). Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo)[4, 3-a: 3', 4'-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 1093–1114. https://doi.org/10.1080/14756366.2021.1915303
   PubMed Web of Science ®Google Scholar
• Asatsuma-Okumura, T., Ito, T., & Handa, H. (2020). Molecular mechanisms of the teratogenic effects of thalidomide. Pharmaceuticals, 13(5), 95. https://doi.org/10.3390/ph13050095
   Web of Science ®Google Scholar
• Ashburn, T. T., & Thor, K. B. (2004). Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews. Drug Discovery, 3(8), 673–683. https://doi.org/10.1038/nrd1468
   PubMed Web of Science ®Google Scholar
• Aziz, N. A. A. M., George, R. F., El‐Adl, K., & Mahmoud, W. R. (2023). Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations. Archiv der Pharmazie, 356(3), e2200465. https://doi.org/10.1002/ardp.202200465
   PubMed Web of Science ®Google Scholar
• Belal, A., Elanany, M. A., Santali, E. Y., Al-Karmalawy, A. A., Aboelez, M. O., Amin, A. H., Abdellattif, M. H., Mehany, A. B., & Elkady, H. (2022). Screening a panel of topical ophthalmic medications against MMP-2 and MMP-9 to investigate their potential in keratoconus management. Molecules, 27(11), 3584. https://doi.org/10.3390/molecules27113584
   PubMed Web of Science ®Google Scholar
• Dhiman, A., Sharma, R., & Singh, R. K. (2022). Target-based anticancer indole derivatives and insight into structure–activity relationship: A mechanistic review update (2018–2021). Acta Pharmaceutica Sinica. B, 12(7), 3006–3027. https://doi.org/10.1016/j.apsb.2022.03.021
   PubMed Web of Science ®Google Scholar
• Eissa, I. H., Ibrahim, M. ‐K., Alesawy, M. S., & El‐Adl, K. (2022). Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking. Archiv der Pharmazie. 355(5), e2100487. https://doi.org/10.1002/ardp.202100487
   PubMed Web of Science ®Google Scholar
• El-Adl, K., El-Helby, A. A., Sakr, H., Eissa, I. H., El-Hddad, S. S. A., & Shoman, F. M. A. (2020). Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme. Bioorganic Chemistry. 102, 104059. https://doi.org/10.1016/j.bioorg.2020.104059
   PubMed Web of Science ®Google Scholar
• El-Adl, K., Ibrahim, M.‐K., Alesawy, M. S., & Eissa, I. H. (2022). Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations. Archiv der Pharmazie. 355(6), e2100506. https://doi.org/10.1002/ardp.202100506
   PubMed Web of Science ®Google Scholar
• Eldehna, W. M., El Hassab, M. A., Elsayed, Z. M., Al-Warhi, T., Elkady, H., Abo-Ashour, M. F., Abourehab, M. A., Eissa, I. H., & Abdel-Aziz, H. A. (2022). Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity. Scientific Reports, 12(1), 1–13. https://doi.org/10.1038/s41598-022-15050-8
   PubMed Web of Science ®Google Scholar
• El-Hddad, S., Sobhy, M., Ayoub, A., & El-Adl, K. (2022). In silico molecular docking, dynamics simulation and repurposing of some VEGFR-2 inhibitors based on the SARS-CoV-2-main-protease inhibitor N3. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2022.2148000
   Google Scholar
• Elkaeed, E. B., Yousef, R. G., Elkady, H., Alsfouk, A. A., Husein, D. Z., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H. (2022). New anticancer theobromine derivative targeting egfrwt and egfrt790m: Design, semi-synthesis, in silico, and in vitro anticancer studies. Molecules, 27(18), 5859. https://doi.org/10.3390/molecules27185859
   PubMed Web of Science ®Google Scholar
• El-Sattar, N. E. A. A., El-Hddad, S. E. S. A., Ghobashy, M. M., Zaher, A. A., & El-Adl, K. (2022). Nanogel-mediated drug delivery system for anticancer agent: pH stimuli responsive poly(ethylene glycol/acrylic acid) nanogel prepared by gamma irradiation. Bioorganic Chemistry, 127, 105972. https://doi.org/10.1016/j.bioorg.2022.105972
   PubMed Web of Science ®Google Scholar
• El-Wareth, A., & Sarhan, A. (2001). On the synthesis and reactions of indole-2-carboxylic acid hydrazide. Monatshefte Fuer Chemie/Chemical Monthly, 132(6), 753–763. https://doi.org/10.1007/s007060170091
   Google Scholar
• El-Zahabi, M. A., Sakr, H., El-Adl, K., Zayed, M., Abdelraheem, A. S., Eissa, S. I., Elkady, H., & Eissa, I. H. (2020). Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorganic Chemistry, 104, 104218. https://doi.org/10.1016/j.bioorg.2020.104218
   PubMed Web of Science ®Google Scholar
• Fischer, E. S., Böhm, K., Lydeard, J. R., Yang, H., Stadler, M. B., Cavadini, S., Nagel, J., Serluca, F., Acker, V., Lingaraju, G. M., Tichkule, R. B., Schebesta, M., Forrester, W. C., Schirle, M., Hassiepen, U., Ottl, J., Hild, M., Beckwith, R. E. J., Harper, J. W., Jenkins, J. L., & Thomä, N. H. (2014). Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide. Nature, 512(7512), 49–53. https://doi.org/10.1038/nature13527
   PubMed Web of Science ®Google Scholar
• Gerlier, D., & Thomasset, N. (1986). Use of MTT colorimetric assay to measure cell activation. Journal of Immunological Methods, 94(1–2), 57–63. https://doi.org/10.1016/0022-1759(86)90215-2
   PubMed Web of Science ®Google Scholar
• Han, Y., Dong, W., Guo, Q., Li, X., & Huang, L. (2020). The importance of indole and azaindole scaffold in the development of antitumor agents. European Journal of Medicinal Chemistry, 203, 112506. https://doi.org/10.1016/j.ejmech.2020.112506
   PubMed Web of Science ®Google Scholar
• Harras, M. F., Sabour, R., Ammar, Y. A., Mehany, A. B., Farrag, A. M., & Eissa, S. I. (2021). Design synthesis and cytotoxicity studies of some novel indomethacin-based heterocycles as anticancer and apoptosis inducing agents. Journal of Molecular Structure, 1228, 129455. https://doi.org/10.1016/j.molstruc.2020.129455
   Web of Science ®Google Scholar
• Kim, J. H., & Scialli, A. R. (2011). Thalidomide: The tragedy of birth defects and the effective treatment of disease. Toxicological Sciences, 122(1), 1–6. https://doi.org/10.1093/toxsci/kfr088
   PubMed Web of Science ®Google Scholar
• Mahony, C., Erskine, L., Niven, J., Greig, N. H., Figg, W. D., & Vargesson, N. (2013). Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro. Proceedings of the National Academy of Sciences of the United States of America, 110(31), 12703–12708. https://doi.org/10.1073/pnas.1307684110
   PubMed Web of Science ®Google Scholar
• Sandes, S. M. S., Heimfarth, L., Brito, R. G., Santos, P. L., Gouveia, D. N., Carvalho, A. M. S., Quintans, J. S. S., da Silva-Júnior, E. F., de Aquino, T. M., França, P. H. B., de Araújo-Júnior, J. X., Albuquerque-Júnior, R. L. C., Zengin, G., Schmitt, M., Bourguignon, J.-J., & Quintans-Júnior, L. J. (2018). Evidence for the involvement of TNF-α, IL-1β and IL-10 in the antinociceptive and anti-inflammatory effects of indole-3-guanylhydrazone hydrochloride, an aromatic aminoguanidine, in rodents. Chemico-Biological Interactions, 286, 1–10. https://doi.org/10.1016/j.cbi.2018.02.026
   PubMed Web of Science ®Google Scholar
• Santana, A. C., Andraus, W., Silva, F. M. O., Sala, A. C. G., Schust, A. S., Neri, L. H. M., Feliciano, R., Pepineli, R., Dellê, H., Ruiz, L. M., de Oliveira-Braga, K. A., Nepomuceno, N. A., Pêgo-Fernandes, P. M., Dos Santos, M. J., de Moraes, E. L., Brasil, S., & Figueiredo, E. G. (2022). Thalidomide modulates renal inflammation induced by brain death experimental model. Transplant Immunology, 75, 101710. https://doi.org/10.1016/j.trim.2022.101710
   PubMed Web of Science ®Google Scholar
• Sharma, V., Kumar, P., & Pathak, D. (2010). Biological importance of the indole nucleus in recent years: a comprehensive review. Journal of Heterocyclic Chemistry, 47(3), NA–NA. https://doi.org/10.1002/jhet.349
   Web of Science ®Google Scholar
• Singh, P., Kaur, S., Sharma, A., Kaur, G., & Bhatti, R. (2017). TNF-α and IL-6 inhibitors: Conjugates of N-substituted indole and aminophenylmorpholin-3-one as anti-inflammatory agents. European Journal of Medicinal Chemistry, 140, 92–103. https://doi.org/10.1016/j.ejmech.2017.09.003
   PubMed Web of Science ®Google Scholar
• Snyder, H., & Pilgrim, F. J. (1948). The preparation of 3-indoleacetic acid; a new synthesis of tryptophol. Journal of the American Chemical Society, 70(11), 3770–3771. https://doi.org/10.1021/ja01191a067
   PubMed Web of Science ®Google Scholar
• Stewart, A. K. (2014). How thalidomide works against cancer. Science (New York, N.Y.), 343(6168), 256–257. https://doi.org/10.1126/science.1249543
   PubMed Web of Science ®Google Scholar
• Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006). Targeting multidrug resistance in cancer. Nature Reviews. Drug Discovery, 5(3), 219–234. https://doi.org/10.1038/nrd1984
   PubMed Web of Science ®Google Scholar
• Taghour, M. S., Mahdy, H. A., Gomaa, M. H., Aglan, A., Eldeib, M. G., Elwan, A., Dahab, M. A., Elkaeed, E. B., Alsfouk, A. A., Khalifa, M. M., Eissa, I. H., & Elkady, H. (2022). Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and antiproliferative evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 2063–2077. https://doi.org/10.1080/14756366.2022.2103552
   PubMed Web of Science ®Google Scholar
• Talaat, R. M. (2010). Soluble angiogenesis factors in sera of Egyptian patients with hepatitis C virus infection: correlation with disease severity. Viral Immunology, 23(2), 151–157. https://doi.org/10.1089/vim.2009.0089
   PubMed Web of Science ®Google Scholar
• Wan, Y., Li, Y., Yan, C., Yan, M., & Tang, Z. (2019). Indole: A privileged scaffold for the design of anti-cancer agents. European Journal of Medicinal Chemistry, 183, 111691. https://doi.org/10.1016/j.ejmech.2019.111691
   PubMed Web of Science ®Google Scholar
• Xu, Q., Huang, L., Liu, J., Ma, L., Chen, T., Chen, J., Peng, F., Cao, D., Yang, Z., Qiu, N., Qiu, J., Wang, G., Liang, X., Peng, A., Xiang, M., Wei, Y., & Chen, L. (2012). Design, synthesis and biological evaluation of thiazole-and indole-based derivatives for the treatment of type II diabetes. European Journal of Medicinal Chemistry, 52, 70–81. https://doi.org/10.1016/j.ejmech.2012.03.006
   PubMed Web of Science ®Google Scholar